CD86 and type 2 diabetes mellitus: As previously published, monocyte-derived macrophages (MDMs) obtained from type 2 diabetes (T2D) patients displayed lower levels of HLA-DR and CD86 compared to MDMs obtained from healthy individuals upon n vitro Mtb infection (48).